Literature DB >> 1091721

Occupational skin cancer: a review.

E A Emmett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091721     DOI: 10.1097/00043764-197501000-00011

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


× No keyword cloud information.
  7 in total

1.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

2.  Squamous cell skin cancer in the north-west of England, 1967--69, and its relation to occupation.

Authors:  C J Whitaker; W R Lee; J E Downes
Journal:  Br J Ind Med       Date:  1979-02

3.  Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis.

Authors:  Nabiha Yusuf; Tahseen H Nasti; Sreelatha Meleth; Craig A Elmets
Journal:  Mol Carcinog       Date:  2009-08       Impact factor: 4.784

4.  Rationale, design, and baseline data of a cross-national randomized trial on the effect of built shade in public parks for sun protection.

Authors:  David B Buller; Suzanne Dobbinson; Dallas R English; Melanie Wakefield; Mary Klein Buller
Journal:  Contemp Clin Trials       Date:  2017-02-07       Impact factor: 2.226

5.  Rationale, design, samples, and baseline sun protection in a randomized trial on a skin cancer prevention intervention in resort environments.

Authors:  David B Buller; Peter A Andersen; Barbara J Walkosz; Michael D Scott; Larry Beck; Gary R Cutter
Journal:  Contemp Clin Trials       Date:  2015-11-22       Impact factor: 2.226

6.  Risk factors of nonmelanoma skin cancer in Ragusa, Sicily: a case-control study.

Authors:  L Gafà; M G Filippazzo; R Tumino; G Dardanoni; F Lanzarone; L Dardanoni
Journal:  Cancer Causes Control       Date:  1991-11       Impact factor: 2.506

7.  Environment and the skin.

Authors:  R R Suskind
Journal:  Environ Health Perspect       Date:  1977-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.